Hicin Pharmaceutical

300584
29.954.28% ( -1.34 )
Delay Closed: Nov 13, 15:00:00

Profile

About

Hicin Pharmaceutical
Hicin Pharmaceutical
300584.SZ

Nanjing Hicin Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of chemical preparations, APIs, and intermediates. The company’s products include landiolol hydrochloride, rivaroxaban, tigecycline, torasemide, cefuroxime sodium, ceftriaxone hydrochloride, ganciclovir sodium, adenosine monophosphate, and adenosine monophosphate for injection; voglibose tablets, lansoprazole enteric-coated tablets, amlodipine besylate tablets, and glucosamine sulfate effervescent tablets; and raw materials, intermediates, and other products. Its products are used in cardiovascular and cerebrovascular, diuretic, anti-infection, digestive system, immune regulation, hypoglycemic, orthopedics, and other treatment areas. Nanjing Hicin Pharmaceutical Co., Ltd.

Profile

Company Name
Nanjing Hicin Pharmaceutical Co., Ltd.
Market
SZSE
Founded
Industry
--
Fiscal Year End
December 31

Related Securities

Industry

Management